$CXDO
Crexendo, Inc. Stock $cxdo

$cxdo Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000165495424002655 Filed on March 05, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$14.29M	$14.16M	$53.20M
YoY Change	14.37%	23.79%	41.66%
Cost Of Revenue	$3.839M	$3.982M	$15.94M
YoY Change	-1.13%	34.66%	90.91%
Gross Profit	$10.45M	$10.18M	$37.26M
YoY Change	21.36%	20.0%	27.58%
Gross Profit Margin	73.13%	71.89%	70.04%
Selling, General & Admin	$7.323M	$6.955M	$28.46M
YoY Change	-6.19%	-8.52%	15.57%
% of Gross Profit	70.1%	68.31%	76.39%
Research & Development	$1.249M	$1.255M	$4.860M
YoY Change	4.87%	-1.26%	22.88%
% of Gross Profit	11.96%	12.33%	13.04%
Depreciation & Amortization	$110.0K	$878.0K	$404.0K
YoY Change	-5.17%	-0.79%	-99.87%
% of Gross Profit	1.05%	8.62%	1.08%
Operating Expenses	$13.80M	$14.13M	$54.89M
YoY Change	-1.86%	-69.32%	-26.76%
Operating Profit	$483.0K	$38.00K	-$1.689M
YoY Change	-130.69%	-100.11%	-95.48%
Interest Expense	$13.00K	-$4.000K	$115.0K
YoY Change	-69.05%	-80.95%	47.44%
% of Operating Profit	2.69%	-10.53%
Other Income/Expense, Net	-$22.00K	$40.00K	$40.00K
YoY Change	-237.5%	-97.43%	-96.71%
Pretax Income	$461.0K	$78.00K	-$264.0K
YoY Change	-129.59%	-100.24%	-99.27%
Income Tax	-$27.00K	$17.00K	$98.00K
% Of Pretax Income	-5.86%	21.79%
Net Earnings	$434.0K	$61.00K	-$362.0K
YoY Change	-127.43%	-100.19%	-98.98%
Net Earnings / Revenue	3.04%	0.43%	-0.68%
Basic Earnings Per Share	$0.02	$0.00	-$0.01
Diluted Earnings Per Share	$0.01	$0.00	-$0.01
COMMON SHARES
Basic Shares Outstanding	26.28M shares	26.03M shares	25.94M shares
Diluted Shares Outstanding	30.14M shares		25.94M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.04M	$10.35M	$10.35M
YoY Change	199.38%	88.99%	88.99%
Cash & Equivalents	$11.04M	$10.35M	$10.35M
Short-Term Investments
Other Short-Term Assets	$23.00K	$35.00K	$1.888M
YoY Change	-95.35%	-94.81%	-2.98%
Inventory	$381.0K	$382.0K	$382.0K
Prepaid Expenses	$899.0K	$508.0K
Receivables	$4.216M	$3.476M	$3.818M
Other Receivables	$884.0K	$856.0K	$856.0K
Total Short-Term Assets	$19.05M	$17.29M	$17.29M
YoY Change	44.73%	40.01%	40.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$590.0K	$670.0K	$1.679M
YoY Change	-32.57%	-79.79%	-61.81%
Goodwill	$9.454M	$9.454M
YoY Change	0.0%	0.0%
Intangibles	$22.80M	$23.56M
YoY Change	-12.1%	-11.86%
Long-Term Investments
YoY Change
Other Assets	$137.0K	$139.0K	$139.0K
YoY Change	-17.47%	-7.33%	-7.33%
Total Long-Term Assets	$38.42M	$38.87M	$38.87M
YoY Change	-5.2%	-10.2%	-10.2%
TOTAL ASSETS
Total Short-Term Assets	$19.05M	$17.29M	$17.29M
Total Long-Term Assets	$38.42M	$38.87M	$38.87M
Total Assets	$57.47M	$56.16M	$56.16M
YoY Change	7.04%	0.95%	0.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$619.0K	$769.0K	$2.066M
YoY Change	-10.42%	-36.24%	-5.79%
Accrued Expenses	$5.002M	$5.951M	$5.220M
YoY Change	16.46%	21.7%	22.36%
Deferred Revenue	$2.898M	$2.390M
YoY Change	-7.8%	-28.4%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$538.0K	$532.0K	$532.0K
YoY Change	-9.43%	3.3%	3.3%
Total Short-Term Liabilities	$9.613M	$10.26M	$10.26M
YoY Change	4.72%	-1.25%	-1.25%
LONG-TERM LIABILITIES
Long-Term Debt	$479.0K	$615.0K	$615.0K
YoY Change	-82.39%	-77.92%	-77.92%
Other Long-Term Liabilities	$610.0K	$671.0K	$671.0K
YoY Change	-31.69%	-32.83%	-32.83%
Total Long-Term Liabilities	$1.089M	$1.286M	$1.286M
YoY Change	-69.86%	-66.01%	-66.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.613M	$10.26M	$10.26M
Total Long-Term Liabilities	$1.089M	$1.286M	$1.286M
Total Liabilities	$10.70M	$11.55M	$11.55M
YoY Change	-16.34%	-18.54%	-18.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$88.03M	-$88.47M
YoY Change	-1.84%	0.59%
Common Stock	$27.00K	$26.00K
YoY Change	3.85%	-98.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$46.77M	$44.61M	$44.61M
YoY Change
Total Liabilities & Shareholders Equity	$57.47M	$56.16M	$56.16M
YoY Change	7.04%	0.95%	0.95%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$434.0K	$61.00K	-$362.0K
YoY Change	-127.43%	-100.19%	-98.98%
Depreciation, Depletion And Amortization	$110.0K	$878.0K	$404.0K
YoY Change	-5.17%	-0.79%	-99.87%
Cash From Operating Activities	-$166.0K	$2.612M	$3.499M
YoY Change	-89.32%	15.88%	-951.34%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$2.000K	$92.00K
YoY Change	-100.0%	-99.87%	-68.17%
Acquisitions			$0.00
YoY Change			-100.0%
Other Investing Activities		$2.000K	$3.792M
YoY Change
Cash From Investing Activities	$0.00	$0.00	$3.700M
YoY Change	-100.0%	-100.0%	-317.26%
FINANCING ACTIVITIES
Cash Dividend Paid			$130.0K
YoY Change			-71.86%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$859.0K	18.00K	-$2.306M
YoY Change	-523.15%	-200.0%	4170.37%
NET CHANGE
Cash From Operating Activities	-$166.0K	2.612M	$3.499M
Cash From Investing Activities	$0.00	0.000	$3.700M
Cash From Financing Activities	$859.0K	18.00K	-$2.306M
Net Change In Cash	$694.0K	2.630M	$4.872M
YoY Change	-138.84%	262.76%	-344.46%
FREE CASH FLOW
Cash From Operating Activities	-$166.0K	$2.612M	$3.499M
Capital Expenditures	$0.00	$2.000K	$92.00K
Free Cash Flow	-$166.0K	$2.610M	$3.407M
YoY Change	-89.38%	251.28%	-586.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001075736
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26130218	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25670773	shares
CY2022Q4	srt	Financing Receivable Allowance For Credit Loss To Nonaccrual Percent FinancingReceivableAllowanceForCreditLossToNonaccrualPercent	0	pure
CY2022Q4	cxdo	Product Warranty Accrual1 ProductWarrantyAccrual1	55000	usd
CY2022	cxdo	Product Warranties Accrual Period Increase Decrease ProductWarrantiesAccrualPeriodIncreaseDecrease	55000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	cxdo	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term4 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4	P5Y3M18D
CY2023	cxdo	Quarterly Dividend QuarterlyDividend	5.000	usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity Registrant Name EntityRegistrantName	Crexendo, Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity File Number EntityFileNumber	001-32277
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0591719
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1615 South 52nd Street
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Tempe
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85281
CY2023	dei	City Area Code CityAreaCode	602
CY2023	dei	Local Phone Number LocalPhoneNumber	714-8500
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Public Float EntityPublicFloat	49538	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	26284202	shares
CY2023	dei	Auditor Firm AuditorFirmId	1013
CY2023	dei	Auditor Name AuditorName	Urish Popeck & Co., LLC
CY2023	dei	Auditor Location AuditorLocation	Pittsburgh, Pennsylvania
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10347000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5475000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	116000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	131000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3476000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3297000	usd
CY2023Q4	cxdo	Allowance For Contract Assets AllowanceForContractAssets	85000	usd
CY2022Q4	cxdo	Allowance For Contract Assets AllowanceForContractAssets	0	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	342000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	318000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	382000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	679000	usd
CY2023Q4	cxdo	Allowance For Equipment Financing Receivable AllowanceForEquipmentFinancingReceivable	56000	usd
CY2022Q4	cxdo	Allowance For Equipment Financing Receivable AllowanceForEquipmentFinancingReceivable	0	usd
CY2023Q4	cxdo	Equipment Financing Receivables Net Current EquipmentFinancingReceivablesNetCurrent	856000	usd
CY2022Q4	cxdo	Equipment Financing Receivables Net Current EquipmentFinancingReceivablesNetCurrent	635000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	1345000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	841000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	508000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	431000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	35000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	674000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	17291000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	12350000	usd
CY2023Q4	cxdo	Allowance For Long Term Equipment Financing Receivable AllowanceForLongTermEquipmentFinancingReceivable	115000	usd
CY2022Q4	cxdo	Allowance For Long Term Equipment Financing Receivable AllowanceForLongTermEquipmentFinancingReceivable	0	usd
CY2023Q4	cxdo	Equipment Financing Receivables Net Non Current EquipmentFinancingReceivablesNetNonCurrent	1768000	usd
CY2022Q4	cxdo	Equipment Financing Receivables Net Non Current EquipmentFinancingReceivablesNetNonCurrent	1255000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	670000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3315000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1009000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1081000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	23556000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	26725000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	9454000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	9454000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	2273000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	1304000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	139000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	150000	usd
CY2023Q4	us-gaap	Assets Assets	56160000	usd
CY2022Q4	us-gaap	Assets Assets	55634000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	769000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1206000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5951000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4890000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	75000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	95000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	457000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	420000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	566000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	363000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	53000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	79000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2390000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3338000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10261000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10391000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	198000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	247000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	23000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	98000	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	592000	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	2605000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	82000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	473000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	752000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	11547000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	14175000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26130218	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25670773	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	26000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	26000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	132888000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	129192000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-88467000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-87946000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	166000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	187000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	44613000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	41459000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	56160000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	55634000	usd
CY2023	cxdo	Service Revenue ServiceRevenue	29668000	usd
CY2022	cxdo	Service Revenue ServiceRevenue	19515000	usd
CY2023	cxdo	Software Solutions Revenue SoftwareSolutionsRevenue	18047000	usd
CY2022	cxdo	Software Solutions Revenue SoftwareSolutionsRevenue	15148000	usd
CY2023	cxdo	Product Revenue ProductRevenue	5484000	usd
CY2022	cxdo	Product Revenue ProductRevenue	2891000	usd
CY2023	us-gaap	Revenues Revenues	53199000	usd
CY2022	us-gaap	Revenues Revenues	37554000	usd
CY2023	cxdo	Cost Of Service Revenue CostOfServiceRevenue	12606000	usd
CY2022	cxdo	Cost Of Service Revenue CostOfServiceRevenue	6711000	usd
CY2023	cxdo	Cost Of Software Solutions Revenue CostOfSoftwareSolutionsRevenue	5627000	usd
CY2022	cxdo	Cost Of Software Solutions Revenue CostOfSoftwareSolutionsRevenue	5336000	usd
CY2023	cxdo	Cost Of Product Revenue CostOfProductRevenue	3331000	usd
CY2022	cxdo	Cost Of Product Revenue CostOfProductRevenue	1637000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14671000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11725000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13793000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	12904000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4860000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3955000	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	32678000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	54888000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	74946000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1689000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-37392000	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	2000	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	0	usd
CY2023	us-gaap	Interest Expense InterestExpense	115000	usd
CY2022	us-gaap	Interest Expense InterestExpense	78000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1459000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2023	us-gaap	Other Income OtherIncome	79000	usd
CY2022	us-gaap	Other Income OtherIncome	1295000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1425000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1217000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-264000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-36175000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	98000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-762000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-362000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-35413000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.54
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.54
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25944748	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22939514	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25944748	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22939514	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-362000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-35413000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-21000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	175000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-21000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	175000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-383000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-35238000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	65933000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4374000	usd
CY2022	cxdo	Vesting Of Restricted Stock Units Amount VestingOfRestrictedStockUnitsAmount	0	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	175000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	816000	usd
CY2022	cxdo	Taxes Paid On The Net Settlement Of Stock Options And Rsus TaxesPaidOnTheNetSettlementOfStockOptionsAndRsus	-290000	usd
CY2022	cxdo	Issuance Of Common Stock In Connection With Business Acquisition Amount IssuanceOfCommonStockInConnectionWithBusinessAcquisitionAmount	6326000	usd
CY2022	us-gaap	Dividends Dividends	462000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-35413000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	41459000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3849000	usd
CY2023	cxdo	Cumulative Effect On Retained Earnings Net Accounting Change CumulativeEffectOnRetainedEarningsNetAccountingChange	-159000	usd
CY2023	cxdo	Vesting Of Restricted Stock Units Amount VestingOfRestrictedStockUnitsAmount	0	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-21000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	241000	usd
CY2023	cxdo	Taxes Paid On The Net Settlement Of Stock Options And Rsus TaxesPaidOnTheNetSettlementOfStockOptionsAndRsus	-264000	usd
CY2023	us-gaap	Dividends Dividends	130000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-362000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	44613000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-362000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-35413000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3573000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2747000	usd
CY2023	cxdo	Deferred Income Tax Expense DeferredIncomeTaxExpense	0	usd
CY2022	cxdo	Deferred Income Tax Expense DeferredIncomeTaxExpense	-936000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	3849000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	4374000	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	32678000	usd
CY2023	cxdo	Non Cash Release Of Sales Tax Accrual NonCashReleaseOfSalesTaxAccrual	0	usd
CY2022	cxdo	Non Cash Release Of Sales Tax Accrual NonCashReleaseOfSalesTaxAccrual	-1435000	usd
CY2023	cxdo	Non Cash Operating Lease Amortization NonCashOperatingLeaseAmortization	-4000	usd
CY2022	cxdo	Non Cash Operating Lease Amortization NonCashOperatingLeaseAmortization	-23000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1459000	usd
CY2023	cxdo	Allowance For Credit Losses AllowanceForCreditLosses	82000	usd
CY2022	cxdo	Allowance For Credit Losses AllowanceForCreditLosses	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-164000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-361000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-109000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-57000	usd
CY2023	cxdo	Increase Decrease In Equipment Financing Receivables IncreaseDecreaseInEquipmentFinancingReceivables	-905000	usd
CY2022	cxdo	Increase Decrease In Equipment Financing Receivables IncreaseDecreaseInEquipmentFinancingReceivables	-616000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	297000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	36000	usd
CY2023	cxdo	Increase Decrease In Contract Costs IncreaseDecreaseInContractCosts	-1473000	usd
CY2022	cxdo	Increase Decrease In Contract Costs IncreaseDecreaseInContractCosts	-788000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-77000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-25000	usd
CY2023	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	0	usd
CY2022	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	11000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	651000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-544000	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	623000	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	246000	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-26000	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	55000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-997000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-360000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3499000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-411000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	92000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	289000	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3792000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1414000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3700000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1703000	usd
CY2023	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-82000	usd
CY2022	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	82000	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	278000	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	95000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	110000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2254000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	90000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	241000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	816000	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	130000	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	462000	usd
CY2023	cxdo	Taxes Paid On The Net Settlement Of Stock Option And Rsus TaxesPaidOnTheNetSettlementOfStockOptionAndRsus	264000	usd
CY2022	cxdo	Taxes Paid On The Net Settlement Of Stock Option And Rsus TaxesPaidOnTheNetSettlementOfStockOptionAndRsus	290000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2306000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-54000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-21000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	175000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4872000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1993000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5475000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7468000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10347000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5475000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-121000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-118000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	115000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	78000	usd
CY2023	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	6326000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	21000	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	9587000	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	4750000	usd
CY2023	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1720000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><strong>Use of Estimates – </strong>In preparing the consolidated financial statements, management makes assumptions, estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements and the reported amounts of net sales and expenses during the reported periods. Specific estimates and judgments include valuation of goodwill and intangible assets in connection with business acquisitions and asset acquisitions, allowances for doubtful accounts, uncertainties related to certain income tax benefits, valuation of deferred income tax assets, valuations of share-based payments, annual incentive bonuses accrual, recoverability of long-lived assets and intangible assets, and product warranty liabilities. Management’s estimates are based on historical experience and on our expectations that are believed to be reasonable. The combination of these factors forms the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from our current estimates and those differences may be material.</p>
CY2023	us-gaap	Revenue Recognition Sales Of Services RevenueRecognitionSalesOfServices	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;"><strong>Service, Software Solutions and Product Revenue Recognition – </strong>Revenue is recognized upon transfer of control of promised services, software solutions or products to customers in an amount that reflects the consideration we expect to receive in exchange for those products or services and excludes any amounts collected on behalf of third parties. We enter into contracts that can include various combinations of products and services, which are generally capable of being distinct and accounted for as separate performance obligations. We recognize revenue for delivered elements only when we determine there are no uncertainties regarding customer acceptance. Changes in the allocation of the sales price between delivered and undelivered elements can impact the timing of revenue recognized but does not change the total revenue recognized on any agreement. Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities. For more detailed information about revenue, see Note 2.</p>
CY2023	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.009	pure
CY2022	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.013	pure
CY2023	us-gaap	Guarantee Obligations Liquidation Proceeds Percentage GuaranteeObligationsLiquidationProceedsPercentage	0.009	pure
CY2022	us-gaap	Guarantee Obligations Liquidation Proceeds Percentage GuaranteeObligationsLiquidationProceedsPercentage	0.023	pure
CY2023	cxdo	Desktop Services DesktopServices	5484000	usd
CY2023	cxdo	Interest Received On Equipment Financing InterestReceivedOnEquipmentFinancing	501000	usd
CY2023	cxdo	Telecommunications Services TelecommunicationsServices	25168000	usd
CY2023	cxdo	Fees Commissions And Other Recognized Over Time FeesCommissionsAndOtherRecognizedOverTime	1899000	usd
CY2023	cxdo	One Time Fees Commissions And Other OneTimeFeesCommissionsAndOther	2100000	usd
CY2023	cxdo	Software Licenses1 SoftwareLicenses1	3454000	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	1412000	usd
CY2023	us-gaap	Revenues Revenues	53199000	usd
CY2023	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	0.10	pure
CY2023	cxdo	Products Services And Fees Recognized At A Point In Time ProductsServicesAndFeesRecognizedAtAPointInTime	12450000	usd
CY2023	cxdo	Subscription Maintenance And Support SubscriptionMaintenanceAndSupport	13181000	usd
CY2023	cxdo	Products Services And Fees Transferred Over Time ProductsServicesAndFeesTransferredOverTime	40749000	usd
CY2023	cxdo	Service Lines ServiceLines	53199000	usd
CY2022	cxdo	Desktop Services DesktopServices	2891000	usd
CY2022	cxdo	Interest Received On Equipment Financing InterestReceivedOnEquipmentFinancing	335000	usd
CY2022	cxdo	Telecommunications Services TelecommunicationsServices	16560000	usd
CY2022	cxdo	Fees Commissions And Other Recognized Over Time FeesCommissionsAndOtherRecognizedOverTime	1709000	usd
CY2022	cxdo	One Time Fees Commissions And Other OneTimeFeesCommissionsAndOther	911000	usd
CY2022	cxdo	Software Licenses1 SoftwareLicenses1	3214000	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	1105000	usd
CY2022	us-gaap	Revenues Revenues	37554000	usd
CY2022	cxdo	Products Services And Fees Recognized At A Point In Time ProductsServicesAndFeesRecognizedAtAPointInTime	8121000	usd
CY2022	cxdo	Subscription Maintenance And Support SubscriptionMaintenanceAndSupport	10829000	usd
CY2022	cxdo	Products Services And Fees Transferred Over Time ProductsServicesAndFeesTransferredOverTime	29433000	usd
CY2022	cxdo	Service Lines ServiceLines	37554000	usd
CY2023Q4	us-gaap	Other Receivables OtherReceivables	3476000	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	3297000	usd
CY2023Q4	us-gaap	Deposit Contracts Assets DepositContractsAssets	342000	usd
CY2022Q4	us-gaap	Deposit Contracts Assets DepositContractsAssets	318000	usd
CY2023Q4	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	2588000	usd
CY2022Q4	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	3585000	usd
CY2023Q4	cxdo	Deposit Contracts Assets Gross DepositContractsAssetsGross	427000	usd
CY2022Q4	cxdo	Deposit Contracts Assets Gross DepositContractsAssetsGross	318000	usd
CY2023Q4	cxdo	Allowanceforcreditlossesof Contract Assets AllowanceforcreditlossesofContractAssets	85000	usd
CY2022Q4	cxdo	Allowanceforcreditlossesof Contract Assets AllowanceforcreditlossesofContractAssets	0	usd
CY2023Q4	us-gaap	Deposit Contracts Assets DepositContractsAssets	342000	usd
CY2022Q4	us-gaap	Deposit Contracts Assets DepositContractsAssets	318000	usd
CY2022Q4	cxdo	Allowances For Credit Losses Of Contract Assets AllowancesForCreditLossesOfContractAssets	0	usd
CY2023Q1	cxdo	Cumulativeeffectofaccountingchange For Allowance C1 CumulativeeffectofaccountingchangeForAllowanceC1	29000	usd
CY2023Q1	cxdo	Allowance For Credit Losses Of Contract Assets Provision AllowanceForCreditLossesOfContractAssetsProvision	2000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	0	usd
CY2023Q2	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	68000	usd
CY2023Q2	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	111000	usd
CY2023Q2	us-gaap	Reinsurance Costs And Recoveries Net ReinsuranceCostsAndRecoveriesNet	0	usd
CY2023Q2	us-gaap	Net Investment In Lease Allowance For Credit Loss Current NetInvestmentInLeaseAllowanceForCreditLossCurrent	144000	usd
CY2023Q3	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	30000	usd
CY2023Q3	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	4000	usd
CY2023Q3	us-gaap	Reinsurance Costs And Recoveries Net ReinsuranceCostsAndRecoveriesNet	0	usd
CY2023Q3	us-gaap	Net Investment In Lease Allowance For Credit Loss Current NetInvestmentInLeaseAllowanceForCreditLossCurrent	110000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	0	usd
CY2023Q1	cxdo	Allowance For Credit Losses Of Contract Assets AllowanceForCreditLossesOfContractAssets	31000	usd
	cxdo	Allowance For Credit Losses Of Contract Assets Provision AllowanceForCreditLossesOfContractAssetsProvision	-8000	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	0	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	0	usd
CY2023Q2	cxdo	Allowance For Credit Losses Of Contract Assets AllowanceForCreditLossesOfContractAssets	23000	usd
	cxdo	Allowance For Credit Losses Of Contract Assets Provision AllowanceForCreditLossesOfContractAssetsProvision	11000	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	0	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	0	usd
CY2023Q3	cxdo	Allowance For Credit Losses Of Contract Assets AllowanceForCreditLossesOfContractAssets	34000	usd
CY2023	cxdo	Allowance For Credit Losses Of Contract Assets Provision AllowanceForCreditLossesOfContractAssetsProvision	53000	usd
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	2000	usd
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	0	usd
CY2023Q4	cxdo	Allowance For Credit Losses Of Contract Assets AllowanceForCreditLossesOfContractAssets	85000	usd
CY2023	cxdo	Schedule Of Pro Forma Informationtabletextblock ScheduleOfProFormaInformationtabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>For the Year Ended December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>(Unaudited, in thousands)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Revenues</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">53,199</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">46,765</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Net loss</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(362</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(35,636</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Earnings per share</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(0.01</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1.40</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table>
CY2023	cxdo	Revenue Revenue	53199000	usd
CY2022	cxdo	Revenue Revenue	46765000	usd
CY2023	cxdo	Net Loss For Acquisition NetLossForAcquisition	-362000	usd
CY2022	cxdo	Net Loss For Acquisition NetLossForAcquisition	-35636000	usd
CY2023	cxdo	Earning Per Share Attributiable EarningPerShareAttributiable	-0.01
CY2022	cxdo	Earning Per Share Attributiable EarningPerShareAttributiable	-1.40
CY2023Q4	cxdo	Trade Receivables TradeReceivables	3476000	usd
CY2022Q4	cxdo	Trade Receivables TradeReceivables	3297000	usd
CY2022Q4	us-gaap	Net Investment In Lease Allowance For Credit Loss Current NetInvestmentInLeaseAllowanceForCreditLossCurrent	131000	usd
CY2023Q1	cxdo	Cumulative Effect Of Accounting Charges CumulativeEffectOfAccountingCharges	18000	usd
CY2023Q1	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	45000	usd
CY2023Q1	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	7000	usd
CY2023Q1	us-gaap	Reinsurance Costs And Recoveries Net ReinsuranceCostsAndRecoveriesNet	0	usd
CY2023Q1	us-gaap	Net Investment In Lease Allowance For Credit Loss Current NetInvestmentInLeaseAllowanceForCreditLossCurrent	187000	usd
CY2023Q4	cxdo	Equipment Financing Receivablesgross EquipmentFinancingReceivablesgross	3888000	usd
CY2022Q4	cxdo	Equipment Financing Receivablesgross EquipmentFinancingReceivablesgross	2666000	usd
CY2023Q4	cxdo	Unearnedincome Of Equipment Financing UnearnedincomeOfEquipmentFinancing	-1093000	usd
CY2022Q4	cxdo	Unearnedincome Of Equipment Financing UnearnedincomeOfEquipmentFinancing	-776000	usd
CY2023Q4	cxdo	Allowance For Credit Losses Of Equipmentfinancingreceivables AllowanceForCreditLossesOfEquipmentfinancingreceivables	-171000	usd
CY2022Q4	cxdo	Allowance For Credit Losses Of Equipmentfinancingreceivables AllowanceForCreditLossesOfEquipmentfinancingreceivables	0	usd
CY2023Q4	cxdo	Accounts Financing Receivable Net AccountsFinancingReceivableNet	2624000	usd
CY2022Q4	cxdo	Accounts Financing Receivable Net AccountsFinancingReceivableNet	1890000	usd
CY2023Q4	cxdo	Equipment Financing Receivables Net Current EquipmentFinancingReceivablesNetCurrent	856000	usd
CY2022Q4	cxdo	Equipment Financing Receivables Net Current EquipmentFinancingReceivablesNetCurrent	635000	usd
CY2023Q4	cxdo	Long Term Equipment Financing Receivables Net LongTermEquipmentFinancingReceivablesNet	1768000	usd
CY2022Q4	cxdo	Long Term Equipment Financing Receivables Net LongTermEquipmentFinancingReceivablesNet	1255000	usd
CY2023Q4	cxdo	Equipment Financing Receivables Net EquipmentFinancingReceivablesNet	2624000	usd
CY2022Q4	cxdo	Equipment Financing Receivables Net EquipmentFinancingReceivablesNet	1890000	usd
CY2023Q4	cxdo	Gross Equipment Financing Receivables Nexttwelvemonths GrossEquipmentFinancingReceivablesNexttwelvemonths	1291000	usd
CY2023Q4	cxdo	Gross Equipment Financing Receivables Yeartwo GrossEquipmentFinancingReceivablesYeartwo	1109000	usd
CY2023Q4	cxdo	Gross Equipment Financing Receivables Yearthree GrossEquipmentFinancingReceivablesYearthree	759000	usd
CY2023Q4	cxdo	Gross Equipment Financing Receivables Year Four GrossEquipmentFinancingReceivablesYearFour	516000	usd
CY2023Q4	cxdo	Gross Equipment Financing Receivables Year Five GrossEquipmentFinancingReceivablesYearFive	213000	usd
CY2023Q4	cxdo	Gross Equipment Financing Receivables Afteryearfive GrossEquipmentFinancingReceivablesAfteryearfive	0	usd
CY2023Q4	cxdo	Equipment Financing Receivables Due EquipmentFinancingReceivablesDue	3888000	usd
CY2023Q4	cxdo	Aging Of Receivables Amount Dues AgingOfReceivablesAmountDues	2624000	usd
CY2022Q4	cxdo	Aging Of Receivables Amount Dues AgingOfReceivablesAmountDues	1890000	usd
CY2023Q4	srt	Financing Receivable Allowance For Credit Loss To Nonaccrual Percent FinancingReceivableAllowanceForCreditLossToNonaccrualPercent	0.061	pure
CY2023Q4	us-gaap	Notes Payable To Bank NotesPayableToBank	1800000	usd
CY2023Q4	cxdo	Closing Costs ClosingCosts	208	usd
CY2023	cxdo	Generating Net Proceeds GeneratingNetProceeds	2000000.0	usd
CY2023Q4	cxdo	Total Equipment Financing Receivables Due TotalEquipmentFinancingReceivablesDue	2795000	usd
CY2022Q4	cxdo	Total Equipment Financing Receivables Due TotalEquipmentFinancingReceivablesDue	1890000	usd
CY2023Q4	cxdo	Total Equipment Financing Receivables Due Gross Write Offs TotalEquipmentFinancingReceivablesDueGrossWriteOffs	33000	usd
CY2022Q4	cxdo	Total Equipment Financing Receivables Due Gross Write Offs TotalEquipmentFinancingReceivablesDueGrossWriteOffs	20000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2891000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2721000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	670000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3315000	usd
CY2023Q4	us-gaap	Purchase Obligation PurchaseObligation	4000000.0	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	404000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	311000	usd
CY2022Q4	us-gaap	Goodwill Fair Value Disclosure GoodwillFairValueDisclosure	32600000	usd
CY2023	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P13Y4M24D
CY2023	cxdo	Developed Technologies DevelopedTechnologies	P3Y8M12D
CY2023	cxdo	Trademarks And Trade Names TrademarksAndTradeNames	P1Y8M12D
CY2023	cxdo	Sales And Marketing Expenses SalesAndMarketingExpenses	2183	usd
CY2022	cxdo	Sales And Marketing Expenses SalesAndMarketingExpenses	1433	usd
CY2023	us-gaap	Payments For Software PaymentsForSoftware	860	usd
CY2022	us-gaap	Payments For Software PaymentsForSoftware	882	usd
CY2023	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	127	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	121	usd
CY2023Q4	cxdo	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	13099000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	36972000	usd
CY2022	cxdo	Centric Telecom Business Acquisition CentricTelecomBusinessAcquisition	5091000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	32609000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	9454000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2884000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2427000	usd
CY2023Q4	cxdo	Accrued Accounts Payable AccruedAccountsPayable	1297000	usd
CY2022Q4	cxdo	Accrued Accounts Payable AccruedAccountsPayable	987000	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1234000	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	846000	usd
CY2023Q4	cxdo	Product Warranty Accrual1 ProductWarrantyAccrual1	25000	usd
CY2023Q4	cxdo	Credit Cards CreditCards	113000	usd
CY2022Q4	cxdo	Credit Cards CreditCards	0	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	398000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	575000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5951000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4890000	usd
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	50000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	55000	usd
CY2022	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	-26000	usd
CY2022	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	24000	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	55000	usd
CY2023	cxdo	Product Warranties Accrual Period Increase Decrease ProductWarrantiesAccrualPeriodIncreaseDecrease	25000	usd
CY2023	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	-32000	usd
CY2023	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	23000	usd
CY2023Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	25000	usd
CY2023	us-gaap	Product Warranty Expense ProductWarrantyExpense	25000	usd
CY2022	us-gaap	Product Warranty Expense ProductWarrantyExpense	29000	usd
CY2023Q4	cxdo	Notes Payable Related Party Classified Current NotesPayableRelatedPartyClassifiedCurrent	843000	usd
CY2022Q4	cxdo	Notes Payable Related Party Classified Current NotesPayableRelatedPartyClassifiedCurrent	1100000	usd
CY2023Q4	us-gaap	Other Notes Payable OtherNotesPayable	206000	usd
CY2022Q4	us-gaap	Other Notes Payable OtherNotesPayable	1925000	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	1049000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	3025000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	457000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	420000	usd
CY2023Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	592	usd
CY2022Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	2605000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	457000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	478000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	114000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	1049000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.31
CY2023	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	700000	usd
CY2023	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2025-02-27
CY2023	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0050	pure
CY2023Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	0	usd
CY2023Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	700000	usd
CY2023Q4	cxdo	Stockbased Compensation Plans Outstanding Option Awards StockbasedCompensationPlansOutstandingOptionAwards	8016	shares
CY2023Q4	cxdo	Stockbased Compensation Plans Available For Future Grants StockbasedCompensationPlansAvailableForFutureGrants	2342	shares
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	10358	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	10358	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2342	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.38
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.88	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.82	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y8M26D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y8M19D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0376	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0299	pure
CY2023	cxdo	Dividends Description DividendsDescription	the company declared and paid quarterly dividends of $0.005, however, the expected annual dividend yield was less than half of one percent during 2023 and 2022. In March 2023, our Board of Directors cancelled the quarterly dividend
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6988843	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.40
CY2022	cxdo	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term4 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4	P4Y6M
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	19829000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1926000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.34
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	960865	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.33
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	301014	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	3.59
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7652964	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.73
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y3M18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3362000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	965500	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.88
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	183521	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.32
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	439144	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	3.04
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7995799	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.64
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y10M24D
CY2023	cxdo	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue	19469	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	7790316	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.64
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y10M24D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	19051000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	6417000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.57
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y10M24D
CY2023	cxdo	Share Based Compensation Arrangement By Share Based Payment Award Option Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	16278	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	5655810	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	2.25
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y1M6D
CY2022	cxdo	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue	3362	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	154000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1576000	usd
CY2024	cxdo	Restricted Stock Units With Service Based Vesting Conditions RestrictedStockUnitsWithServiceBasedVestingConditions	13334	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	39138	shares
CY2021Q4	cxdo	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	4.05
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	592500	shares
CY2022	cxdo	Share Based Compensation Arrangements By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice	2.70
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	475653	shares
CY2022	cxdo	Share Based Compensation Arrangements By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice	2.50
CY2022	cxdo	Share Based Compensation Arrangements By Share Based Payment Award Equity Instruments Other Than Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	155985	shares
CY2022Q4	cxdo	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	3.62
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	255000	shares
CY2023	cxdo	Share Based Compensation Arrangements By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice	1.87
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	397651	shares
CY2023	cxdo	Share Based Compensation Arrangements By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageExercisePrice	2.57
CY2023	cxdo	Share Based Compensation Arrangements By Share Based Payment Award Equity Instruments Other Than Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	13334	shares
CY2023Q4	cxdo	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	1.73
CY2023	cxdo	Share Based Compensation Arrangements By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice	1.87
CY2022	cxdo	Share Based Compensation Arrangements By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice	2.70
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	793000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	1167000	usd
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	3221000	usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	2798000	usd
CY2023	us-gaap	Restricted Stock Expense RestrictedStockExpense	628000	usd
CY2022	us-gaap	Restricted Stock Expense RestrictedStockExpense	1576000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	3849000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	4374000	usd
CY2023	us-gaap	Interest Expense Other InterestExpenseOther	4000	usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	7000	usd
CY2023	cxdo	Share Based Compensation Expense By Financial Statments ShareBasedCompensationExpenseByFinancialStatments	3849000	usd
CY2022	cxdo	Share Based Compensation Expense By Financial Statments ShareBasedCompensationExpenseByFinancialStatments	4374000	usd
CY2023Q4	cxdo	Tax Benefit Related To Stock Compensation Expense On Net Deferred Tax Assets TaxBenefitRelatedToStockCompensationExpenseOnNetDeferredTaxAssets	747000	usd
CY2022Q4	cxdo	Tax Benefit Related To Stock Compensation Expense On Net Deferred Tax Assets TaxBenefitRelatedToStockCompensationExpenseOnNetDeferredTaxAssets	510000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	98000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	174000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-98000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-174000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	875000	usd
CY2023	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	61000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	936000	usd
CY2023	cxdo	Income Tax Benefit Provision IncomeTaxBenefitProvision	-98000	usd
CY2022	cxdo	Income Tax Benefit Provision IncomeTaxBenefitProvision	762000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	56000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	7596000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-69000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	697000	usd
CY2023	cxdo	Write Off Goodwill WriteOffGoodwill	0	usd
CY2022	cxdo	Write Off Goodwill WriteOffGoodwill	-6848000	usd
CY2023	cxdo	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowances IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowances	219000	usd
CY2022	cxdo	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowances IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowances	-785000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-418000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	105000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	114000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-3000	usd
CY2023	cxdo	Income Tax Benefit Provisions IncomeTaxBenefitProvisions	-98000	usd
CY2022	cxdo	Income Tax Benefit Provisions IncomeTaxBenefitProvisions	762000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	392000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	490000	usd
CY2023Q4	cxdo	Deferred Tax Assets Deferred Income Other DeferredTaxAssetsDeferredIncomeOther	466000	usd
CY2022Q4	cxdo	Deferred Tax Assets Deferred Income Other DeferredTaxAssetsDeferredIncomeOther	698000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6451000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7783000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	747000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	510000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	20000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	127000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	8076000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	9608000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4782000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3179000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3294000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	6429000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	41000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	134000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	723000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	455000	usd
CY2023Q4	cxdo	Intangible Asset Current IntangibleAssetCurrent	-2530000	usd
CY2022Q4	cxdo	Intangible Asset Current IntangibleAssetCurrent	-5840000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3294000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	6429000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023Q4	cxdo	Deferred Taxes Realizable Amount DeferredTaxesRealizableAmount	4782000	usd
CY2023Q4	cxdo	Deferred Tax Asset Valuation Allowance DeferredTaxAssetValuationAllowance	4782	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	98000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	193000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	486000	usd
CY2022Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	486000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Owned Accumulated Depreciation PropertyPlantAndEquipmentOwnedAccumulatedDepreciation	337000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Owned Accumulated Depreciation PropertyPlantAndEquipmentOwnedAccumulatedDepreciation	259000	usd
CY2023	us-gaap	Other Expenses OtherExpenses	40000	usd
CY2023	cxdo	Amortization Expense Included In General And Administrative Expenses AmortizationExpenseIncludedInGeneralAndAdministrativeExpenses	5000	usd
CY2022	cxdo	Amortization Expense Included In General And Administrative Expenses AmortizationExpenseIncludedInGeneralAndAdministrativeExpenses	5000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	683000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	77000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	205000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	21000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	179000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	3000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	134000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	0	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1201000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	101000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	64000	usd
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	3000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1137000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	98000	usd
CY2023	cxdo	Weighted Average Remaining Lease Term Operating Leases WeightedAverageRemainingLeaseTermOperatingLeases	P2Y7M6D
CY2023	cxdo	Weighted Average Remaining Lease Term Finance Leases WeightedAverageRemainingLeaseTermFinanceLeases	P1Y4M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.048	pure
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.024	pure
CY2023	cxdo	Operating Cash Flows From Operating Leases OperatingCashFlowsFromOperatingLeases	674000	usd
CY2023	cxdo	Operating Cash Flows From Finance Leases OperatingCashFlowsFromFinanceLeases	5000	usd
CY2023	cxdo	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	-2254000	usd
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	517000	usd
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	365000	usd
CY2023	cxdo	Cloud Telecommunications Technology Services Revenue CloudTelecommunicationsTechnologyServicesRevenue	-124000	usd
CY2022	cxdo	Cloud Telecommunications Technology Services Revenue CloudTelecommunicationsTechnologyServicesRevenue	-3948000	usd
CY2023	cxdo	Capitalized Computer Software Solutions CapitalizedComputerSoftwareSolutions	-140000	usd
CY2022	cxdo	Capitalized Computer Software Solutions CapitalizedComputerSoftwareSolutions	-32227000	usd
CY2023	cxdo	Total Other Income Expense Net TotalOtherIncomeExpenseNet	-264000	usd
CY2022	cxdo	Total Other Income Expense Net TotalOtherIncomeExpenseNet	-36175000	usd
CY2023	us-gaap	Revenues Revenues	53199000	usd
CY2022	us-gaap	Revenues Revenues	37554000	usd
CY2023Q1	us-gaap	Revenues Revenues	12491000	usd
CY2023Q2	us-gaap	Revenues Revenues	12670000	usd
CY2023Q3	us-gaap	Revenues Revenues	13874000	usd
CY2023Q4	us-gaap	Revenues Revenues	14164000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3809000	usd
CY2023Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3613000	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3502000	usd
CY2023Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3747000	usd
CY2023Q1	cxdo	General And Administrative Expenses GeneralAndAdministrativeExpenses	3997000	usd
CY2023Q2	cxdo	General And Administrative Expenses GeneralAndAdministrativeExpenses	3167000	usd
CY2023Q3	cxdo	General And Administrative Expenses GeneralAndAdministrativeExpenses	3309000	usd
CY2023Q4	cxdo	General And Administrative Expenses GeneralAndAdministrativeExpenses	3320000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1191000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1138000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1275000	usd
CY2023Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1255000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	14065000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	13187000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	13510000	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	14126000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1574000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-517000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	364000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	38000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	16000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1373000	usd
CY2023Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	40000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1558000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-521000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1737000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	78000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33000	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1582000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-545000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	1704000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	61000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q1	us-gaap	Revenues Revenues	8158000	usd
CY2022Q2	us-gaap	Revenues Revenues	8846000	usd
CY2022Q3	us-gaap	Revenues Revenues	9108000	usd
CY2022Q4	us-gaap	Revenues Revenues	11442000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2584000	usd
CY2022Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2771000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2732000	usd
CY2022Q4	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3638000	usd
CY2022Q1	cxdo	General And Administrative Expenses GeneralAndAdministrativeExpenses	3249000	usd
CY2022Q2	cxdo	General And Administrative Expenses GeneralAndAdministrativeExpenses	2757000	usd
CY2022Q3	cxdo	General And Administrative Expenses GeneralAndAdministrativeExpenses	2800000	usd
CY2022Q4	cxdo	General And Administrative Expenses GeneralAndAdministrativeExpenses	4098000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	304000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1229000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1151000	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1271000	usd
CY2022Q4	cxdo	Goddd goddd	32678	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	9551000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	9698000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	9652000	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	46045000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1393000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-852000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-544000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-34603000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-28000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-126000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-184000	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1555000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1421000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-978000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-728000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-33048000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-201000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-82000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-32000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-447000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1220000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-896000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-696000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-32601000	usd
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33

Files In Submission

Name	View Source	Status
cxdo-20231231_cal.xml	Edgar Link	unprocessable
cxdo-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001654954-24-002655-index-headers.html	Edgar Link	pending
0001654954-24-002655-index.html	Edgar Link	pending
0001654954-24-002655.txt	Edgar Link	pending
0001654954-24-002655-xbrl.zip	Edgar Link	pending
cxdo-20231231.xsd	Edgar Link	pending
cxdo_10k.htm	Edgar Link	pending
cxdo_10kimg108.jpg	Edgar Link	pending
cxdo_ex1011.htm	Edgar Link	pending
cxdo_ex211.htm	Edgar Link	pending
cxdo_ex231.htm	Edgar Link	pending
cxdo_ex311.htm	Edgar Link	pending
cxdo_ex312.htm	Edgar Link	pending
cxdo_ex321.htm	Edgar Link	pending
cxdo_ex322.htm	Edgar Link	pending
cxdo_ex41.htm	Edgar Link	pending
cxdo_ex971.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
cxdo-20231231_def.xml	Edgar Link	unprocessable
cxdo-20231231_lab.xml	Edgar Link	unprocessable
cxdo_10k_htm.xml	Edgar Link	completed
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CXDO
Crexendo, Inc. Stock $cxdo

2024 Q1 Form 10-K Financial Statement

#000165495424002655 Filed on March 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CXDO Crexendo, Inc. Stock $cxdo

2024 Q1 Form 10-K Financial Statement

#000165495424002655 Filed on March 05, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CXDO
Crexendo, Inc. Stock $cxdo